Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1977 Jul;29(1):100-9.

Suppressor T cells prevent experimental autoimmune encephalomyelitis in mice

Suppressor T cells prevent experimental autoimmune encephalomyelitis in mice

C C Bernard. Clin Exp Immunol. 1977 Jul.

Abstract

Immune suppression (immunoprotection) in experimental autoimmune encephalomyelitis (EAE) was studied in (SJL X BALB/c)F1 mice using inocular of mouse spinal cord homogenate (MSCH), or mouse basic protein of myelin (M-BPM), in Freund's incomplete adjuvant (FIA). Such immunization specifically recruited lymphoid cells which markedly suppressed the capacity of effector lymph node cells from appropriately immunized syngeneic mice to transfer adoptively EAE. Suppression was demonstrable with transfer of bone marrow and spleen cells, but not with lymph nodes or thymus cells. Adoptively transferred suppression was maximal when cells were injected 9-30 days after the suppressive injection. Inhibition of EAE by suppressor cells was specific for the relavant antigen BPM, and required viable cells. Treatment of cells with anti-Thy-1 serum before transfer abolished their suppressor activity. After adoptive transfer of suppressor cells into syngeneic recipients subsequently immunized for EAE, there was inhibition of EAE and reduced cell-mediated immune response to BPM as judged by macrophage migration inhibition assays. Hence, in mice at least, immuno-protection against EAE is explicable by recruitment of suppressor T lymphocytes with the dual capacities of inhibiting development of effector T cells after antigenic stimulation, and of blocking their damaging effects on the antigen in the central nervous system.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Immunol. 1969 Dec;103(6):1248-53 - PubMed
    1. J Immunol. 1969 Jun;102(6):1431-6 - PubMed
    1. J Immunol. 1973 Oct;111(4):1067-70 - PubMed
    1. J Immunol. 1973 Jan;110(1):139-43 - PubMed
    1. Immunochemistry. 1972 Oct;9(10):1013-9 - PubMed

LinkOut - more resources